[Black Agnes]

http://www.ncbi.nlm.nih.gov/pubmed/24462697

They’ve already got a drug, favipiravir, that is in phase III clinical trials (human trials) as an anti-influenza drug. It’s a wide spectrum drug against RNA viruses:

http://www.allfordrugs.com/2014/01/09/favipiravir-phase-3-clinical-trials-for-investigational-flu-treatment-drug-started/

Japan is already stockpiling this particular compound in the event of an outbreak of influenza variants. South Korea has indicated they will be purchasing this drug as well, in the event of an Ebola outbreak there.

Your guess is as good as mine as to why this compound has received ZERO exposure in the US media.

[Black Agnes]

http://www.japantimes.co.jp/news/2014/08/08/national/science-health/ebola-drug-japan-may-emerge-among-key-candidates/

Foreign media discussion that includes mention of favipiravir.

[OneWingedShark]

Your guess is as good as mine as to why this compound has received ZERO exposure in the US media.

My guess: What you don't know can kill you.